Better Therapeutics Inc. (BTTX)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

0.01

7300.00%

Pre-market Jun 20, 2024, 09:30 AM EDT

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY22	FY21	FY20	FY19
Revenue	-	-	8.00K	18.00K
Cost of Revenue	2.73M	1.62M	682.00K	898.00K
Gross Profit	-2.73M	-1.62M	-674.00K	-880.00K
Operating Income	-38.26M	-30.56M	-6.32M	-5.77M
Interest Income	1.49K	185.00	100.00	11.00
Pretax Income	-39.75M	-40.49M	-6.23M	-5.78M
Net Income	-39.76M	-40.34M	-6.39M	-5.79M
Selling & General & Admin	21.82M	11.12M	2.67M	2.60M
Research & Development	16.44M	19.44M	2.98M	2.29M
Other Expenses	-	-	-	-
Operating Expenses	38.26M	30.56M	5.65M	4.89M
Interest Expense	1.49M	185.00K	100.00K	11.00K
Selling & Marketing Expenses	6.98M	2.34M	216.00K	406.00K
Cost & Expenses	38.26M	30.56M	6.33M	5.79M
Income Tax	7.00K	-153.00K	153.00K	11.00K
Shares Outstanding (Basic)	23.56M	23.60M	7.56M	23.60M
Shares Outstanding (Diluted)	23.56M	23.60M	7.56M	23.60M
EPS (Basic)	-1.69	-1.71	-0.85	-0.25
EPS (Diluted)	-1.69	-1.71	-0.85	-0.25
EBITDA	-38.26M	-30.56M	-6.25M	-5.70M
Depreciation & Amortization	2.73M	1.62M	75.00K	72.00K